Anavex Life Sciences Corp AVXL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
5.09UNCH (UNCH)
Volume
16,781
Close
5.09quote price arrow up+0.03 (+0.59%)
Volume
960,833
52 week range
4.48 - 10.45
Loading...
  • Open5.01
  • Day High5.20
  • Day Low4.98
  • Prev Close5.06
  • 52 Week High10.45
  • 52 Week High Date12/19/23
  • 52 Week Low4.48
  • 52 Week Low Date03/25/24

Key Stats

  • Market Cap417.953M
  • Shares Out82.11M
  • 10 Day Average Volume1.78M
  • Dividend-
  • Dividend Yield-
  • Beta0.55
  • YTD % Change-45.33

KEY STATS

  • Open5.01
  • Day High5.20
  • Day Low4.98
  • Prev Close5.06
  • 52 Week High10.45
  • 52 Week High Date12/19/23
  • 52 Week Low4.48
  • 52 Week Low Date03/25/24
  • Market Cap417.953M
  • Shares Out82.11M
  • 10 Day Average Volume1.78M
  • Dividend-
  • Dividend Yield-
  • Beta0.55
  • YTD % Change-45.33

RATIOS/PROFITABILITY

  • EPS (TTM)-0.54
  • P/E (TTM)-9.50
  • Fwd P/E (NTM)-8.70
  • EBITDA (TTM)-51.665M
  • ROE (TTM)-31.88%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Anavex Life Sciences Corp

 

Profile

MORE
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound ANAVEX 2-73 is being...
Christopher Missling Ph.D.
Chairman of the Board, President, Chief Executive Officer, Company Secretary
Sandra Boenisch CPA
Principal Financial Officer, Treasurer
Address
630 5Th Avenue, 20Th Floor
New York, NY
10111
United States

Top Peers

SYMBOLLASTCHG%CHG
GLUE
Monte Rosa Therapeutics Inc
7.05+0.01+0.14%
TNYA
Tenaya Therapeutics Inc
5.23+0.07+1.36%
CRBP
Corbus Pharmaceuticals Holdings Inc
39.24+3.67+10.32%
LYRA
Lyra Therapeutics Inc
6.22-0.31-4.75%
INZY
Inozyme Pharma Inc
7.66+0.27+3.65%